| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,390 | 1,500 | 11:45 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Aliko Scientific Launches CYTOfast Auto at MEDICA 2026, Expanding Into High-Volume Screening Markets | 353 | Business Wire | Expanding Aliko Scientific's reach into high-volume laboratories and large-scale screening programs, within a global cytology market projected to reach USD 38.2 billion by 2030
New fully... ► Artikel lesen | |
| 21.09. | ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million | 304 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned... ► Artikel lesen | |
| 15.09. | Aliko Scientific Launches Probantes in Brazil and Establishes a New Molecular Diagnostic Development and Commercial Platform for South America | 424 | Business Wire | Currently being established in Brazil, Probantes is wholly owned by Aliko Scientific and based in Anápolis, Goiás, a major pharmaceutical and life sciences hub.
Probantes will serve... ► Artikel lesen | |
| 07.09. | Aliko Scientific Successfully Launches U.S. Business Development Collaboration With Partner International at ADLM 2026, the World's Largest Molecular Diagnostics Exhibition | 416 | Business Wire | Strong first joint initiative at ADLM (Association for Diagnostics Laboratory Medicine) 2026, providing direct access to major international diagnostics players Significant interest generated... ► Artikel lesen | |
| 24.08. | Aliko Scientific Provides a Financial Update Following the Publication of its FY 2025 Results and Reaffirms Its Business Momentum | 733 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, today provides additional financial... ► Artikel lesen | |
| 05.08. | Aliko Scientific Signs New Distribution Agreements in Romania and Saudi Arabia, Strengthening Its International Commercial Network | 913 | Business Wire | €1.92 million in Romania and €2.05 million in Saudi Arabia in five-year minimum contractual purchase commitments Agreements covering Aliko Scientific's liquid-based cytology, FISH, microscopy... ► Artikel lesen | |
| 05.08. | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 213 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 30.07. | Aliko Scientific Reports its Full-Year Financial Results for 2025 and Provides an Update on Its Latest Developments | 952 | Business Wire | Total revenue up 52.6% to €1.64 million (vs. €1.08 million in 2024), driven by Hospitex' full-year contribution and the progressive rollout of Aliko Scientific's offering
EBITDA improved... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 23.07. | Aliko Scientific Tochter unterzeichnet Vereinbarung für Krebs-Screening in Usbekistan | - | Investing.com Deutsch | ||
| 23.07. | Aliko Scientific unit signs Uzbekistan cancer screening deal | 2 | Investing.com | ||
| 23.07. | Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project | 419 | Business Wire | Confirmation of the growing international interest in Urine24 and significant recognition of Aliko Scientific's expertise in large-scale oncological diagnostic solutions Immediate launch... ► Artikel lesen | |
| 15.06. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 215 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 0,5... ► Artikel lesen | |
| 25.05. | Aliko Scientific gründet Joint Venture in Brasilien zur Herstellung von FISH-Sonden | 1 | Investing.com Deutsch | ||
| 25.05. | Aliko Scientific signs Brazil JV to manufacture FISH probes | 1 | Investing.com | ||
| 25.05. | Aliko Scientific SA: Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture | 628 | Business Wire | Aliko Scientific signs Brazilian JV with BioBrasil to manufacture proprietary FISH probes for global diagnostic markets New "instrument probes" model aims to create recurring revenues and... ► Artikel lesen | |
| 19.05. | Aliko Scientific SA: Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital | 465 | Business Wire | Execution of the long-term strategy focused on recurring revenue and developing opportunities for sustainable growth Contract with a potential total value of approximately €620,000, over... ► Artikel lesen | |
| 11.05. | Aliko Scientific SA: Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona | 542 | Business Wire | Regulatory News:
Aliko Scientific SA ("Aliko Scientific" or the "Company") (Euronext Growth Paris: ALIKO), an industrial and financial holding company focused on advanced oncology diagnostics... ► Artikel lesen | |
| 10.03. | Aliko Scientific: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market | 628 | Business Wire | Regulatory News:
Hospitex International, part of Aliko Scientific Group (Ticker: ALIKO), announces the signing of a strategic distribution agreement with Naturneed for the commercialization... ► Artikel lesen | |
| 24.02. | Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform | 575 | Business Wire | Regulatory News:
Aliko Scientific SA (Ticker: ALIKO) previously Ikonisys SA, announces a highly successful first market appearance at WHX Labs Dubai, the world's largest medical trade exhibition... ► Artikel lesen | |
| 18.02. | Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan | 630 | Business Wire | Regulatory News:
Aliko Scientific SA (Ikonisys SA Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 46,880 | +0,04 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| BILLIONTOONE | 96,20 | 0,00 % | BillionToOne auf der Stifel Healthcare Conference 2026: Wachstumsdynamik gewinnt an Breite | ||
| LIFESTANCE HEALTH GROUP | 14,475 | -0,03 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,545 | 0,00 % | NSE - Starling Oncology, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| FRESENIUS | 54,09 | +0,43 % | AKTIE IM FOKUS: Fresenius steigen weiter - Fokus auf Wachstum geschärft | FRANKFURT (dpa-AFX) - Der weiter geschärfte Fokus auf Wachstum beschert den Aktien von Fresenius am Donnerstag auf dem höchsten Kursniveau seit acht Jahren weitere Zuwächse. Unter den stärksten Werten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,550 | -1,02 % | Siemens im Fokus: Umsatz zieht dank USA und China an - Entflechtung von Siemens Healthineers an Aktionäre geplant | MÜNCHEN (IT-Times) - Die Siemens AG hat heute ihre Ergebnisse für das vierte Quartal des Geschäftsjahres 2025/2026 veröffentlicht und ein zweistelliges Umsatzwachstum verzeichnet. Siemens Aktie: Quartalsergebnis... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 27,970 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Announces Publication of ACE-PAS, the Largest Prospective Real-World Wearable Defibrillator Study, in the Journal of Cardiovascular Electrophysiology | ||
| FRESENIUS MEDICAL CARE | 39,660 | -0,48 % | Aktien Frankfurt: Konjunkturhoffnung treibt Dax erstmals über 27.000 Punkte | FRANKFURT (dpa-AFX) - Gute Stimmung am deutschen Aktienmarkt: Der Dax erklomm am Donnerstag ein Rekordhoch und stieg kurzzeitig sogar über die viel beachtete Marke von 27.000 Punkten. Gegen Mittag... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 25,265 | +0,02 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,480 | +0,13 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 11,620 | 0,00 % | RBC Capital reiterates Aveanna Healthcare stock rating at Outperform | ||
| NEUROPACE | 7,960 | 0,00 % | Mizuho cuts NeuroPace stock price target to $12 on weak quarter | ||
| RXSIGHT | 5,300 | 0,00 % | RxSight, Inc.: RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer | ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 23,540 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| CLEARPOINT NEURO | 8,310 | 0,00 % | ClearPoint Neuro: Operatives Momentum, neue Partnerschaften und Turnaround-Hoffnung für Spezialanbieter im Neuro-Markt | ClearPoint Neuro gewinnt an operativem Momentum: Das Unternehmen verzeichnet wachsendes Interesse in mehreren Geschäftssparten, treibt die Kommerzialisierung seiner Technologieplattform voran und positioniert... ► Artikel lesen |